The main driver of sepsis market growth will be the launch of multiple first-in-class products that directly manage sepsis and septic shock, including monoclonal antibodies (mAbs), new antibiotics, and drugs with novel mechanisms of action.
from Medindia Health News https://ift.tt/3CRn9v0
No comments:
Post a Comment